• By Concept
  • By Last Name
  • By Full Text

Smith, Mark A

Grant Detail

The grant detail shows the name of the PI, active dates of the project, the funding institute and the abstract of the grant. This abstract is what is used to create the fingerprint of the grant. If any publications referencing this grant are found in the data, they will be listed here as well.



NEUROFIBRILLARY PATHOLOGY IN AGING

Grundke-Iqbal, Inge

1 June 1981 - 30 June 2002
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 1,730,520

FY 1999
3R01NS018105-17S1
$ 50,000
FY 1999
3R01NS018105-17S2
$ 35,000
FY 1998
5R01NS018105-17
$ 0
FY 1997
5R01NS018105-16
$ 164,190
FY 1996
5R01NS018105-15
$ 158,208
FY 1995
5R01NS018105-14
$ 151,887
FY 1994
2R01NS018105-13
$ 141,051
FY 1993
5R01NS018105-12
$ 124,332
FY 1992
5R01NS018105-11
$ 116,149
FY 1991
2R01NS018105-10A2
$ 110,348
FY 1989
5R01NS018105-09
$ 83,048
FY 1988
5R01NS018105-08
$ 78,931
FY 1987
2R01NS018105-07
$ 94,259
FY 1986
5R01NS018105-06
$ 74,011
FY 1985
5R01NS018105-05
$ 74,669
FY 1984
2R01NS018105-04
$ 64,752
FY 1983
5R01NS018105-03
$ 75,197
FY 1982
5R01NS018105-02
$ 67,858
FY 1981
7R01NS018105-01
$ 66,630
 
 
$ 1,730,520
Abstract

The long term objective of this proposal is to learn the role of cytoskeletal alterations in the degeneration of neurons in normal aged and Alzheimer disease (AD), a major public health problem in modern society with its rapidly increasing elderly population. AD is characterized clinically by progressive dementia, and histopathologically by an intraneuronal accumulation of masses of paired helical filaments (PHF), disrupting the normal cytoskeleton, and an extracellular deposition of Beta-amyloid in the brain. The presence of PHF correlates with dementia. The PHF are made up of abnormally hyperphosphorylated tau. Hyperphosphorylated tau also occurs in the nonpolymerized form in the neuronal cytoplasm and might be one of the earliest and most critical events contributing to the cytoskeletal pathology in AD. To understand the generation and catabolism of the unpolymerized hypephosphorylated tau (AD P-tau) and its interaction with the normal cytoskeleton, it is proposed to: 1. Determine by radioimmunoassay the relative levels of phosphorylation with site-specific antibodies and compare the agree of phosphorylation at defined sites within AD P-tau and between AD P-tau and PHF tau; 2. Study the interaction of AD P-tau with the microtubule system by determining the interaction kinetics between AD P-tau and normal tau and by analyzing the effect of AD P-tau in vitro on preformed microtubules and in vivo on the microtubule network of cultured cells; 3. Generate hyperphosphorylated tau-in cultured cells by treatment with phosphatase inhibitors and kinase simulators and compare the hyperphosphorylated tau with normal human tau and AD P-tau with respect to its polypeptide pattern and levels of phosphorylation sites, and 4. Study the rate of synthesis and turnover of normal and hyperphosphorylated tau in cultured radiolabeled cells and determine whether tau is degraded mostly by the lysosomal pathway and whether the hyperphosphorylation of tau makes it more resistant to degradation. Phosphorylation sites will be determined by radioimmuno- slot-blot assays. The interaction of AD P-tau with normal tau will be examined in vitro by an overlay radioimmuno assay, and in vivo by intracellular injections and immunocytochemistry. Cell culture models of hyperphosphorylated tau and processing of tau will be investigated by pulse chase studies and Western blots and immunocytochemist.

94 Resulting Publications

Scientific Context

This section shows information that has been computed by using the fingerprint of the grant, including related publications, related experts and related grants - all with fingerprints representing significant amounts of overlap between their fingerprint and this grant. The red dots indicate whether those experts or terms actually appear within this grant, showing potential and actual connections.

Related Grants

Related Publications